Small Pharma Inc. announced that Mr. Peter Rands, co-founder, Chief Innovation & Intellectual Property Officer and former Chief Executive Officer of the Company, has left his positions as an Executive Officer and Director of the Company and its subsidiaries, effective as of July 1, 2023. Following Mr. Rands’ departure from his role as Chief Innovation & Intellectual Property Officer, Emma Hodge, the company’s current Head of Intellectual Property, will lead IP development and strategy. Ms Hodge, who joined Small Pharma in 2021, is a qualified patent attorney, with over 20 years’ of experience specializing in the pharmaceutical industry, having spent the majority of her career at Pfizer and Novartis.